Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.7K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Histone Modification02:32

Histone Modification

15.7K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.7K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

9.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.2K
Hematopoiesis01:21

Hematopoiesis

8.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.3K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

4.9K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaptable centriole biogenesis via the intrinsically disordered protein ALMS1.

Nature communications·2026
Same author

Inflammatory immune modulators of AML lung infiltration and respiratory failure.

Nature immunology·2026
Same author

Molecular architecture of the ciliary base in mammalian multiciliated cells.

bioRxiv : the preprint server for biology·2026
Same author

The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs.

Science translational medicine·2026
Same author

PRECLINICAL ACTIVITY OF THE B7-H3- TARGETING ANTIBODY-DRUG CONJUGATE (ADC) VOBRAMITAMAB DUOCARMAZINE (VOBRA DUO) IN PEDIATRIC SOLID TUMORS.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse Models.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening
05:44

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening

Published on: January 26, 2024

1.2K

Aging-associated decrease in the histone acetyltransferase KAT6B is linked to altered hematopoietic stem cell

Eraj Shafiq Khokhar1, Sneha Borikar2, Elizabeth Eudy2

  • 1Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA; The Jackson Laboratory, Bar Harbor, ME, USA.

Experimental Hematology
|February 5, 2020
PubMed
Summary

Aging hematopoietic stem cells (HSCs) show biased myeloid production. The histone acetyltransferase Kat6b regulates this process, decreasing with age, and targeting KAT6B may improve aged immune function.

More Related Videos

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.5K
Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
10:17

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

Published on: September 24, 2021

3.0K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening
05:44

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening

Published on: January 26, 2024

1.2K
Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing
05:27

Author Spotlight: Advancing Hematopoietic Research Using Stromal Cell Isolation for Single Cell Sequencing

Published on: January 26, 2024

1.5K
Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
10:17

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

Published on: September 24, 2021

3.0K

Area of Science:

  • Hematology
  • Epigenetics
  • Immunology

Background:

  • Aged hematopoietic stem cells (HSCs) exhibit skewed differentiation towards myeloid lineages.
  • Understanding the gene regulatory mechanisms of HSC aging is crucial for enhancing immune function in older individuals.

Purpose of the Study:

  • To identify epigenetic factors regulating HSC aging and myeloid differentiation.
  • To investigate the role of histone acetyltransferase Kat6b in HSC aging and immune function.

Main Methods:

  • Short hairpin RNA (shRNA) screen of epigenetic factors.
  • Analysis of Kat6b expression in HSCs during aging.
  • In vitro and in vivo knockdown of Kat6b in long-term HSCs (LT-HSCs).
  • Transcriptome analysis of Kat6b-manipulated HSCs.

Main Results:

  • Kat6b was identified as a regulator of myeloid cell production from hematopoietic progenitor cells.
  • Kat6b expression decreases in LT-HSCs with aging.
  • Kat6b knockdown in young LT-HSCs induced myeloid-biased differentiation and reduced erythroid production.
  • Transcriptome analysis revealed altered aging, macrophage, self-renewal, and multilineage priming gene signatures.

Conclusions:

  • KAT6B is a novel epigenetic regulator of hematopoietic differentiation.
  • KAT6B levels are critical for maintaining balanced HSC differentiation during aging.
  • Targeting KAT6B presents a potential strategy to improve immune function in aged individuals.